|
Mean and median serum and urinary phytoestrogen levels in the European Prospective into Cancer-Norfolk breast cancer case – control study |
|||||
| Median |
% detected |
Median |
% detected |
P valuea |
|
|
|
|||||
| Full study |
Controls (n = 952) |
Cases (n = 237) |
|||
| Serum (ng/ml) |
|||||
| Genistein |
5.00 |
91 |
4.77 |
93 |
0.608 |
| Daidzein |
2.00 |
86 |
1.98 |
91 |
0.206 |
| Equol |
0.01 |
29 |
0.01 |
33 |
0.005 |
| o-Desmethylangolensin |
0.10 |
52 |
0.10 |
59 |
0.284 |
| Glycitein |
0.01 |
29 |
0.01 |
40 |
<0.0001 |
| Enterodiol |
0.10 |
58 |
0.20 |
68 |
0.023 |
| Enterolactone |
5.83 |
98 |
5.00 |
98 |
0.088 |
| Urine (μg/mmol creatinine) |
Controls (n = 851) |
Cases (n = 213) |
|||
| Genistein |
5.71 |
84 |
6.47 |
86 |
0.071 |
| Daidzein |
14.82 |
92 |
14.63 |
94 |
0.134 |
| Equol |
0.011 |
47 |
0.011 |
52 |
0.403 |
| o-Desmethylangolensin |
0.92 |
73 |
0.58 |
75 |
0.486 |
| Glycitein |
0.62 |
69 |
1.29 |
79 |
<0.0001 |
| Enterodiol |
6.45 |
86 |
7.25 |
91 |
0.188 |
| Enterolactone |
112.70 |
97 |
102.07 |
97 |
0.366 |
| Oestrogen receptor-positive subgroup |
Controls (n = 381) |
Cases (n = 112) |
|||
| Serum (ng/ml) |
|||||
| Genistein |
4.80 |
89 |
4.55 |
89 |
0.446 |
| Daidzein |
1.83 |
84 |
1.89 |
87 |
0.846 |
| Equol |
0.01 |
37 |
0.01 |
41 |
0.637 |
| o-Desmethylangolensin |
0.10 |
51 |
0.10 |
56 |
0.569 |
| Glycitein |
0.01 |
25 |
0.01 |
29 |
0.372 |
| Enterodiol |
0.10 |
59 |
0.17 |
61 |
0.645 |
| Enterolactone |
6.60 |
98 |
6.25 |
98 |
0.739 |
| Urine (μg/mmol creatinine) |
Controls (n = 344) |
Cases (n = 102) |
|||
| Genistein |
5.67 |
84 |
4.74 |
80 |
0.675 |
| Daidzein |
15.30 |
93 |
13.09 |
92 |
0.948 |
| Equol |
0.04 |
51 |
0.46 |
61 |
0.073 |
| o-Desmethylangolensin |
1.29 |
70 |
1.02 |
72 |
0.899 |
| Glycitein |
0.51 |
65 |
0.56 |
70 |
0.195 |
| Enterodiol |
6.62 |
85 |
8.82 |
91 |
0.075 |
| Enterolactone |
123.99 |
97 |
136.55 |
99 |
0.044 |
|
aP value from the Wilcoxon – Mann – Whitney test. | |||||
Ward et al. Breast Cancer Research 2008 10:R32 doi:10.1186/bcr1995 |
|||||